Volume 68, Issue 1, Pages (July 2015)

Slides:



Advertisements
Presentazioni simili
Emilin1 Links TGF-β Maturation to Blood Pressure Homeostasis Luca Zacchigna, Carmine Vecchione, Antonella Notte, Michelangelo Cordenonsi, Sirio Dupont,
Advertisements

Identification of a New Locus for Medullary Cystic Disease, on Chromosome 16p12 Francesco Scolari, Daniela Puzzer, Antonio Amoroso, Gianluca Caridi, Gian.
Position paper of the Italian Association for the Study of the Liver (AISF): The multidisciplinary clinical approach to hepatocellular carcinoma Luigi.
Che-1 phosphorylation by ATM/ATR and Chk2 kinases activates p53 transcription and the G2/M checkpoint Tiziana Bruno, Francesca De Nicola, Simona Iezzi,
Evaluation of Clensia®, a new low-volume PEG bowel preparation in colonoscopy: Multicentre randomized controlled trial versus 4L PEG  Cristiano Spada,
Venoarterial Extracorporeal Membrane Oxygenation for Acute Fulminant Myocarditis in Adult Patients: A 5-Year Multi-Institutional Experience  Roberto Lorusso,
Long-term clinical evaluation in patients with Parkinson's disease and early autonomic involvement  Claudio Lucetti, Gianna Gambaccini, Paolo Del Dotto,
The prognostic value of biological markers in paediatric Hodgkin lymphoma  Piero Farruggia, Giuseppe Puccio, Alessandra Sala, Alessandra Todesco, Salvatore.
Volume 61, Issue 3, Pages (March 2012)
Does Stent Placement for Advanced Colon Cancer Increase the Risk of Perforation During Bevacizumab-Based Therapy?  Vincenzo Cennamo, Lorenzo Fuccio, Vita.
How to manage children who have come into contact with patients affected by tuberculosis  Laura Lancella, Andrea Lo Vecchio, Elena Chiappini, Marina Tadolini,
Cetuximab plus irinotecan after irinotecan failure in elderly metastatic colorectal cancer patients: Clinical outcome according to KRAS and BRAF mutational.
Reversible Cognitive Frailty, Dementia, and All-Cause Mortality
Acute diplopia in the pediatric Emergency Department
Current challenges in HER2-positive breast cancer
Volume 126, Issue 5, Pages (November 2004)
Heart failure and anemia: Effects on prognostic variables
Assessing the role of eptifibatide in patients with diffuse coronary disease undergoing drug-eluting stenting: The INtegrilin plus STenting to Avoid myocardial.
Seconda Riunione Napoli Novembre 2017
A 15-year experience of two hundred and twenty five consecutive right hepatectomies  Giovanni Battista Levi Sandri, Marco Colasanti, Giovanni Vennarecci,
Volume 146, Issue 4, Pages (October 2014)
Aortic neck evolution after endovascular repair with TriVascular Ovation stent graft  Gianmarco de Donato, MD, Francesco Setacci, MD, Luciano Bresadola,
A Cytologic Assay for Diagnosis of Food Hypersensitivity in Patients With Irritable Bowel Syndrome  Antonio Carroccio, Ignazio Brusca, Pasquale Mansueto,
Critical Reviews in Oncology / Hematology
An unusual case of drug-resistant epilepsy in a child with non-celiac gluten sensitivity  Oliviero Bruni, Claudia Dosi, Anna Luchetti, Martina della Corte,
Volume 119, Issue 1, Pages (July 2000)
Volume 117, Issue 5, Pages (November 1999)
MP84-13 A NEW APPROACH FOR AN IMPROVED PSA DOUBLING TIME COMPUTATION FOR SELECTING PATIENTS CANDIDATE TO TIMELY SALVAGE RADIOTHERAPY FOR A BIOCHEMICAL.
Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer 
Volume 57, Issue 6, Pages (June 2010)
Volume 47, Issue 3, Pages (March 2005)
MP11-18 THE ROLE OF PRIMARY SURGERY AND EXTERNAL BEAM RADIATION THERAPY IN THE MANAGEMENT OF NON-METASTATIC DUCTAL PROSTATE CANCER: 20-YEAR OUTCOMES.
Long-Term Outcome After Antiviral Therapy of Patients With Hepatitis C Virus Infection and Decompensated Cirrhosis  Angelo Iacobellis, Francesco Perri,
Genome Search in Celiac Disease
Does Stent Placement for Advanced Colon Cancer Increase the Risk of Perforation During Bevacizumab-Based Therapy?  Vincenzo Cennamo, Lorenzo Fuccio, Vita.
BNP in mitral valve restrictive annuloplasty for ischemic mitral regurgitation  Domenico Paparella, Pietro Giorgio Malvindi, Roberta Romito, Massimo Iacoviello,
Switching from Transdermal Drugs: An Observational “N of 1” Study of Fentanyl and Buprenorphine  Sebastiano Mercadante, MD, Giampiero Porzio, MD, Fabio.
Impact of New Drugs on the Long-Term Follow-Up of Upfront Tandem Autograft– Allograft in Multiple Myeloma  Luisa Giaccone, Andrea Evangelista, Francesca.
Allogeneic Hematopoietic Cell Transplantation from Unrelated Donors in Multiple Myeloma: Study from the Italian Bone Marrow Donor Registry  Roberto Passera,
Volume 147, Issue 1, Pages (July 2014)
Lacosamide in pediatric and adult patients: Comparison of efficacy and safety  Alberto Verrotti, Giulia Loiacono, Antonella Pizzolorusso, Pasquale Parisi,
A method for chest drainage after pediatric cardiac surgery: A prospective randomized trial  Salvatore Agati, MD, Carmelo Mignosa, MD, FETCS, Placido.
Safety for Patients With Celiac Disease of Baked Goods Made of Wheat Flour Hydrolyzed During Food Processing  Luigi Greco, Marco Gobbetti, Renata Auricchio,
Multicenter Experience Using Total Lymphoid Irradiation and Antithymocyte Globulin as Conditioning for Allografting in Hematological Malignancies  Giuseppe.
Neuropsychological and behavioural aspects in children and adolescents with idiopathic epilepsy at diagnosis and after 12 months of treatment  Paolo Piccinelli,
European Urology Oncology
Volume 117, Issue 5, Pages (November 1999)
Volume 51, Issue 4, Pages (April 2007)
Diagnostic Performance of Low-Dose Computed Tomography Screening for Lung Cancer over Five Years  Giulia Veronesi, MD, Patrick Maisonneuve, DipEng, Lorenzo.
Prevalence of Hyperhomocysteinemia in Adult Gluten-Sensitive Enteropathy at Diagnosis: Role of B12, Folate, and Genetics  Simone Saibeni, Anna Lecchi,
‘Money for nothing’. The role of robotic-assisted laparoscopy for the treatment of endometriosis  Nicola Berlanda, Maria Pina Frattaruolo, Giorgio Aimi,
A randomized study on eversion versus standard carotid endarterectomy: Study design and preliminary results: The Everest Trial  Piergiorgio Cao, MD, Giuseppe.
Preliminary results of endovascular aneurysm sealing from the multicenter Italian Research on Nellix Endoprosthesis (IRENE) study  Bruno Gossetti, MD,
P Role of microRNAs as Biomarkers of Malignant Mesothelioma in Patients with Pleural Effusion  Alessandro Palleschi, Valentina Bollati, Chiara.
Appropriateness of learning curve for carotid artery stenting: An analysis of periprocedural complications  Fabio Verzini, MD, Piergiorgio Cao, MD, FRCS,
Clinical and Translational Radiation Oncology
Personalized Medicine in Psychiatry
Outcomes of Elderly Patients with ST-Elevation or Non-ST-Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention  Nuccia Morici,
Discoid or segmental rectosigmoid resection for deep infiltrating endometriosis: a case- control study  Francesco Fanfani, M.D., Anna Fagotti, M.D., Maria.
Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase–producing K. pneumoniae  M. Falcone, A. Russo, A.
Food Hypersensitivity as a Cause of Rectal Bleeding in Adults
European Urology Oncology
Is there a role for soy isoflavones in the therapeutic approach to polycystic ovary syndrome? Results from a pilot study  Daniela Romualdi, M.D., Barbara.
MA01.09 Mortality, Survival and Incidence Rates in the ITALUNG Randomised Lung Cancer Screening Trial (ITALY)  Eugenio Paci, Donella Puliti, Andrea Lopes.
High-Dose Melphalan Plus Thiotepa as Conditioning Regimen before Second Autologous Stem Cell Transplantation for “De Novo” Multiple Myeloma Patients:
AAN 9. Influence of Earthquakes on the Occurrence of Aortic Aneurysm Ruptures  Edoardo Pasqui, MD, Gianmarco de Donato, MD, Emiliano Chisci, MD, Stefano.
A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: A controlled trial  Claudio Bilardi, Pietro Dulbecco, Patrizia.
Venoarterial Extracorporeal Membrane Oxygenation for Acute Fulminant Myocarditis in Adult Patients: A 5-Year Multi-Institutional Experience  Roberto Lorusso,
Traumatic rupture of the thoracic aorta: Ten years of delayed management  Davide Pacini, MD, Emanuela Angeli, MD, Rossella Fattori, MD, Luigi Lovato, MD,
Switching from Transdermal Drugs: An Observational “N of 1” Study of Fentanyl and Buprenorphine  Sebastiano Mercadante, MD, Giampiero Porzio, MD, Fabio.
Transcript della presentazione:

Volume 68, Issue 1, Pages 147-153 (July 2015) Clinical Outcomes of Castration-resistant Prostate Cancer Treatments Administered as Third or Fourth Line Following Failure of Docetaxel and Other Second-line Treatment: Results of an Italian Multicentre Study  Orazio Caffo, Ugo De Giorgi, Lucia Fratino, Daniele Alesini, Vittorina Zagonel, Gaetano Facchini, Donatello Gasparro, Cinzia Ortega, Marcello Tucci, Francesco Verderame, Enrico Campadelli, Giovanni Lo Re, Giuseppe Procopio, Roberto Sabbatini, Maddalena Donini, Franco Morelli, Donata Sartori, Paolo Zucali, Francesco Carrozza, Alessandro D’Angelo, Giovanni Vicario, Francesco Massari, Daniele Santini, Teodoro Sava, Caterina Messina, Giuseppe Fornarini, Leonardo La Torre, Riccardo Ricotta, Michele Aieta, Claudia Mucciarini, Fable Zustovich, Sveva Macrini, Salvatore Luca Burgio, Sandra Santarossa, Carmine D’Aniello, Umberto Basso, Sara Tarasconi, Enrico Cortesi, Consuelo Buttigliero, Fiorella Ruatta, Antonello Veccia, Vincenza Conteduca, Francesca Maines, Enzo Galligioni  European Urology  Volume 68, Issue 1, Pages 147-153 (July 2015) DOI: 10.1016/j.eururo.2014.10.014 Copyright © 2014 European Association of Urology Terms and Conditions

Fig. 1 New agent–based treatments after docetaxel failure. AA=abiraterone acetate; CAB=cabazitaxel; ENZ=enzalutamide. European Urology 2015 68, 147-153DOI: (10.1016/j.eururo.2014.10.014) Copyright © 2014 European Association of Urology Terms and Conditions

Fig. 2 Overall survival from start of third-line treatment, by prognostic group (median values: group 1: 5 mo; group 2: 9 mo; group 3: 20 mo; log-rank p<0.001). European Urology 2015 68, 147-153DOI: (10.1016/j.eururo.2014.10.014) Copyright © 2014 European Association of Urology Terms and Conditions

Fig. 3 Overall survival from start of docetaxel by prognostic group (median values: group 1: 24 mo; group 2: 32 mo; group 3: 80 mo; log-rank p<0.001). European Urology 2015 68, 147-153DOI: (10.1016/j.eururo.2014.10.014) Copyright © 2014 European Association of Urology Terms and Conditions